ONCOLOGY PHARMA, INC.
ONCOLOGY PHARMA, INC. is a registered legal entity registered in United States under 3587164, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 15 July 2013 and lists its registered address as SAN FRANCISCO, United States. 1 shareholder is on record for ONCOLOGY PHARMA, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 21 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for ONCOLOGY PHARMA, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Studio Investment Management Llc, holding 100% — a majority holding.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Studio Investment Management Llc | 100% | California Secretary of State — bizfile Online |
Officers
5
The Director of ONCOLOGY PHARMA, INC. currently on record is CHUCK WAGNER; five officers are currently on record for ONCOLOGY PHARMA, INC., filed with California Secretary of State — bizfile Online.
The register reports 26 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at ONCOLOGY PHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns ONCOLOGY PHARMA, INC.?
One shareholder is currently on record for ONCOLOGY PHARMA, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Studio Investment Management Llc, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is ONCOLOGY PHARMA, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for ONCOLOGY PHARMA, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does ONCOLOGY PHARMA, INC. have on record?
1 shareholder is shown on record for ONCOLOGY PHARMA, INC..
What is ONCOLOGY PHARMA, INC.'s company registration number?
ONCOLOGY PHARMA, INC.'s registration number is 3587164, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.
Is ONCOLOGY PHARMA, INC. still an active company?
ONCOLOGY PHARMA, INC.'s status on California Secretary of State — bizfile Online is listed as active.
When was ONCOLOGY PHARMA, INC. incorporated?
ONCOLOGY PHARMA, INC. was incorporated on 15 July 2013, according to California Secretary of State — bizfile Online.
What is ONCOLOGY PHARMA, INC.'s registered address?
The registered address on file for ONCOLOGY PHARMA, INC. is SAN FRANCISCO, United States.
Who are the officers/directors of ONCOLOGY PHARMA, INC.?
The Director of ONCOLOGY PHARMA, INC. currently on record is CHUCK WAGNER; five officers are currently on record for ONCOLOGY PHARMA, INC., filed with California Secretary of State — bizfile Online. Management authority at ONCOLOGY PHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to ONCOLOGY PHARMA, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to ONCOLOGY PHARMA, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access ONCOLOGY PHARMA, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like ONCOLOGY PHARMA, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 21 October 2026.